The bills will next move to the House floor for a vote and then head over to Conference with the Senate. Here is a breakdown of the funding allocations applicable to our profession:
Labor-HHS-Education Funding Bill
National Institutes of Health (NIH): $47 billion – $5.5 billion or 13.2% above FY2020
- Annual appropriations: $42 billion
- A $500 million increase over fiscal year (FY) 2020 (1.2%)
- Cancer Moonshot: $195 million
- Combating Antibiotic-Resistant Bacteria: NIAID to maintain funding for related research
- Supplemental emergency appropriations: $5 billion
- $2.5 billion to be distributed across NIH proportionate to each institutes FY2020 funding level
- Increases in funding for each institute by at least 7%
Centers for Disease Control and Prevention (CDC): $8 billion – $232 million above FY2020
- Inflammatory bowel disease: $1 million for health promotion
- Colorectal cancer: $44.2 million for cancer prevention and control
- $1 million increase to identify risk factors associated with the increase in colorectal cancer among younger adults and trends based on race and socioeconomic status.
- Antibiotic resistance Initiative: $175 million to fund research activities that address aspects of antibiotic resistance.
- Supplemental emergency appropriations: $9 billion to improve preparedness for public health emergencies.
Health Resources and Services Administration (HRSA): $7.2 billion
- Health centers program: $1.65 billion
- Bureau of Health Professions: $1.2 billion to support health care workforce
- Rural health programs, including increases for telehealth and rural hospitals: $334 million
Agency for Healthcare Research and Quality (AHRQ): $343 million – $5 million over FY2020
- Combating antimicrobial resistance: $10 million
Biomedical Advanced Research and Development Authority (BARDA): $562 million
- Advanced research and development of antibiotics: $500 million
- Supplemental emergency appropriations: $4.5 billion
Defense Funding Bill
Defense Health Program (DHP):
- Congressionally Directed Medical Research Program (CDMRP): $1.02 billion
- Pancreatic Cancer Research Program: $10 million – $4 million over FY2020
- Peer-reviewed Cancer Research Program (PRCRP): $110 million
- The following GI related cancers remained on the program’s list of allowable areas of research:
- Stomach cancer
- Colorectal cancer
- Liver cancer
- Esophageal cancer
Military Construction and Veterans Affairs Funding Bill
Veterans’ Affairs (VA)
- VA Medical and Prosthetic Research Program: $840 million, an increase of $40 million (5%) over FY 2020
As the Senate moves through the appropriations process, we will be in consistent communication with congressional offices to ensure:
- AGA’s submitted congressional language on AGA’s FMT National Registry is placed in the Labor-HHS-Education report
- NIH is funded at $44.7 billion
- The VA Medical and Prosthetic Research Program is funded at $860 million
- GI-specific diseases are included as topic areas in the CDMRP
- The Pancreatic Cancer Research Program continues as a separate line item in the CDMRP
